Apogee Therapeutics, Inc.
APGE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Assets | – | – | – |
| Cash & Equivalents | $142 | $118 | $152 |
| Short-Term Investments | $379 | $277 | $0 |
| Receivables | $5 | $1 | $0 |
| Inventory | $0 | $0 | $0 |
| Other Curr. Assets | $4 | $2 | $0 |
| Total Curr. Assets | $530 | $398 | $152 |
| Property Plant & Equip (Net) | $13 | $3 | $0 |
| Goodwill | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 |
| Long-Term Investments | $210 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 |
| Total NC Assets | $224 | $3 | $0 |
| Other Assets | $0 | $0 | $0 |
| Total Assets | $754 | $401 | $152 |
| Liabilities | – | – | – |
| Payables | $1 | $2 | $0 |
| Short-Term Debt | $3 | $1 | $0 |
| Tax Payable | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 |
| Other Curr. Liab. | $24 | $17 | $10 |
| Total Curr. Liab. | $29 | $21 | $10 |
| LT Debt | $9 | $1 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 |
| Total NC Liab. | $9 | $1 | $0 |
| Other Liabilities | $0 | $0 | $0 |
| Cap. Leases | $9 | $1 | $0 |
| Total Liabilities | $37 | $21 | $10 |
| Equity | – | – | – |
| Pref Stock | $0 | $0 | $177 |
| Common Stock | $0 | $0 | $2 |
| Retained Earnings | -$306 | -$124 | -$40 |
| AOCI | $1 | $0 | $2 |
| Other Equity | $1,022 | $503 | $0 |
| Total Equity | $717 | $380 | $142 |
| Supplemental Information | – | – | – |
| Minority Interest | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $754 | $401 | $152 |
| Net Debt | -$130 | -$116 | -$152 |